相关实验视频

Updated: Jun 24, 2025

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

通过通过ERRα信号传递改善神经元线粒体功能,APOE2可以防止Aβ病理

Zhiyuan Ning^1,2,3, Ying Liu^1,2,3, Mengyao Wan^1,2,3

¹Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.

Cellular & molecular biology letters

|June 12, 2024

概括

APOE2基因变异可能通过通过与雌激素相关的受体α (ERRα) 信号来增强神经线粒体功能,从而提供潜在的治疗点,从而保护阿尔茨海默病.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
细胞生物学细胞生物学

背景情况:

阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,与阿波利波蛋白E (APOE) 基因型相关的敏感性有所不同.
APOE2等位基因与AD风险降低有关,这表明它具有潜在的神经保护作用,尽管其机制尚不清楚.

研究的目的:

阐明APOE2在阿尔茨海默病中的神经保护作用背后的分子机制.
研究APOE2在神经线粒体功能和细胞能量代谢中的作用.

主要方法:

来自APOE2和APOE3载体 (ROSMAP队列) 的单核和大量RNA测序数据的分析.
在SH-SY5Y细胞和AD模型小鼠中验证,评估线粒体功能和认知行为.
研究了APOE2与雌激素相关受体α (ERRα) 之间的相互作用.

主要成果:

APOE2与细胞压力和能量代谢密切相关,特别是在神经元中,这种情况被β-粉样蛋白 (Aβ) 加剧.
过度表达APOE2减轻了Aβ诱导的线粒体功能障碍和反应性氧物种的产生.
通过与雌激素相关受体α (ERRα) 相互作用,APOE2可能会产生保护作用,这本身表明线粒体保护作用并改善AD模型中的认知功能.

结论:

APOE2通过激活ERRα信号来增强神经线粒体功能.
这种ERRα通路激活代表了阿尔茨海默病的潜在治疗策略.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.亚脂蛋白 E 是一种阿波利波蛋白.贝塔-粉样化物 (Aβ)这是ESRRA的ESRRA.线粒体中的线粒体.神经元神经元是一个神经元.

更多相关视频

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Assaying β-amyloid Toxicity using a Transgenic C. elegans Model

Assaying β-amyloid Toxicity using a Transgenic C. elegans Model

Published on: October 9, 2010

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

The Unfolded Protein Response

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...